{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:11:17Z","timestamp":1790295077951,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00210-025-03933-2","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T09:37:50Z","timestamp":1740735470000},"page":"10581-10595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["From computational screening to zebrafish testing: repurposing of doxazosin, donepezil, and dolutegravir for neuroprotective potential in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-6739","authenticated-orcid":false,"given":"Karishma M.","family":"Rathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali R.","family":"Undale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra D.","family":"Wavhale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdous Sayed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan N.","family":"Karwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"3","key":"3933_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22184","volume":"85","author":"D Akkaya","year":"2024","unstructured":"Akkaya D, Seyhan G, Sari S, Barut B (2024) In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer\u2019s disease. Drug Dev Res 85(3):e22184. https:\/\/doi.org\/10.1002\/ddr.22184","journal-title":"Drug Dev Res"},{"key":"3933_CR2","first-page":"1448","volume":"31","author":"M Alzweiri","year":"2022","unstructured":"Alzweiri M, Sweidan K, Saleh OA, Al-Helo T (2022) Synthesis and evaluation of new 2-oxo-1, 2-dihydroquinoline-3-carboxamides as potent inhibitors against acetylcholinesterase enzyme. MedChem Research 31:1448\u20131460","journal-title":"MedChem Research"},{"issue":"5","key":"3933_CR3","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/med.21434","volume":"37","author":"SO Bachurin","year":"2017","unstructured":"Bachurin SO, Bovina EV, Ustyugov AA (2017) Drugs in clinical trials for Alzheimer\u2019s disease: the major trends. Med Res Rev 37(5):1186\u20131225. https:\/\/doi.org\/10.1002\/med.21434","journal-title":"Med Res Rev"},{"key":"3933_CR4","first-page":"1","volume-title":"Neuromethods","author":"JM Cachat","year":"2011","unstructured":"Cachat JM, Canavello PR, Elkhayat SI, Bartels BK, Hart PC, Elegante MF et al (2011) Video aided analysis of zebrafish locomotion and anxiety-related behavioural responses. Neuromethods. Humana Press, Totowa, pp 1\u201314"},{"key":"3933_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.neuroscience.2019.02.005","volume":"404","author":"BP Coelho","year":"2019","unstructured":"Coelho BP, Gaelzer MM, dos Santos Petry F, Hoppe JB, Trindade VMT, Salbego CG, Guma FT (2019) Dual effect of doxazosin: anticancer activity on SH-SY5Y neuroblastoma cells and neuroprotection on an in vitro model of Alzheimer\u2019s disease. Neuroscience 404:314\u2013325","journal-title":"Neuroscience"},{"key":"3933_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2023.139894","volume":"340","author":"AAS De Oliveira","year":"2023","unstructured":"De Oliveira AAS, Vieira LC, Dreossi SC, Dorta DJ, Gravato C, da Silva Ferreira ME, de Oliveira DP (2023) Integrating morphological, biochemical, behavioural, and molecular approaches to investigate developmental toxicity triggered by tebuthiuron in zebrafish (Danio rerio). Chemosphere 340:139894. https:\/\/doi.org\/10.1016\/j.chemosphere.2023.139894","journal-title":"Chemosphere"},{"key":"3933_CR7","doi-asserted-by":"publisher","unstructured":"Dey S, Thamaraikani T, Vellapandian C (2024) Advancing Alzheimer\u2019s research with zebrafish models: current insights, addressing challenges, and charting future courses. Cureus 16(8). https:\/\/doi.org\/10.7759\/cureus.66935","DOI":"10.7759\/cureus.66935"},{"key":"3933_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.beproc.2023.104885","volume":"209","author":"CP Dos Santos","year":"2023","unstructured":"Dos Santos CP, de Oliveira MN, Silva PF, Luchiari AC (2023) Relationship between boldness and exploratory behavior in adult zebrafish. Behav Proc 209:104885. https:\/\/doi.org\/10.1016\/j.beproc.2023.104885","journal-title":"Behav Proc"},{"key":"3933_CR9","doi-asserted-by":"publisher","unstructured":"Foster EG, Sillman B, Liu Y, Summerlin M, Kumar V, Sajja BR, ... Bade AN (2023) Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model. Front Pharmacol 14, 1294579. https:\/\/doi.org\/10.3389\/fphar.2023.1294579","DOI":"10.3389\/fphar.2023.1294579"},{"key":"3933_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fnbeh.2019.00180","volume":"13","author":"S Haghani","year":"2019","unstructured":"Haghani S, Karia M, Cheng RK, Mathuru AS (2019) An automated assay system to study novel tank induced anxiety. Front Behav Neurosci 13:180. https:\/\/doi.org\/10.3389\/fnbeh.2019.00180","journal-title":"Front Behav Neurosci"},{"issue":"2","key":"3933_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209570","volume":"103","author":"A Hart","year":"2024","unstructured":"Hart A, Aldridge G, Zhang Q, Narayanan NS, Simmering JE (2024) Association of terazosin, doxazosin, or alfuzosin use and risk of dementia with Lewy bodies in men. Neurology 103(2):e209570","journal-title":"Neurology"},{"issue":"13","key":"3933_CR12","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400558R","volume":"38","author":"C Huang","year":"2024","unstructured":"Huang C, Hoque MT, Qu QR, Henderson J, Bendayan R (2024) Antiretroviral drug dolutegravir induces inflammation at the mouse brain barriers. FASEB J 38(13):e23790","journal-title":"FASEB J"},{"issue":"5","key":"3933_CR13","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s43440-023-00515-y","volume":"75","author":"A Jakimiuk","year":"2023","unstructured":"Jakimiuk A, Piechal A, Wierci\u0144ska-Drapa\u0142o A, Nowaczyk A, Mirowska-Guzel D (2023) Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies. Pharmacol Rep 75(5):1138\u20131151","journal-title":"Pharmacol Rep"},{"key":"3933_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuro.2022.07.004","volume":"92","author":"K Kaur","year":"2022","unstructured":"Kaur K, Narang RK, Singh S (2022) AlCl\u2083 induced learning and memory deficit in zebrafish. Neurotoxicology 92:67\u201376. https:\/\/doi.org\/10.1016\/j.neuro.2022.07.004","journal-title":"Neurotoxicology"},{"key":"3933_CR15","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.csbj.2024.05.036","volume":"23","author":"L Luo","year":"2024","unstructured":"Luo L, Yan T, Yang L, Zhao M (2024) Aluminum chloride and D-galactose induced a zebrafish model of Alzheimer\u2019s disease with cognitive deficits and aging. Comput Struct Biotechnol J 23:2230\u20132239","journal-title":"Comput Struct Biotechnol J"},{"issue":"10","key":"3933_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrd4594","volume":"14","author":"CA MacRae","year":"2015","unstructured":"MacRae CA, Peterson RT (2015) Zebrafish as tools for drug discovery. Nat Rev Drug Discovery 14(10):721\u2013731. https:\/\/doi.org\/10.1038\/nrd4594","journal-title":"Nat Rev Drug Discovery"},{"key":"3933_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.19040\/ecocycles.v4i2.108","volume":"4","author":"I Magyary","year":"2018","unstructured":"Magyary I (2018) Recent advances and future trends in zebrafish bioassays for aquatic ecotoxicology. Ecocycles 4:12\u201318","journal-title":"Ecocycles"},{"key":"3933_CR18","doi-asserted-by":"publisher","unstructured":"Maximino C, Marques de Brito T, Dias CAG de M, Gouveia A Jr, Morato S (2010) Scototaxis as anxiety-like behaviour in fish. Nature Protocols 5(2):209\u2013216. https:\/\/doi.org\/10.1038\/nprot.2009.225","DOI":"10.1038\/nprot.2009.225"},{"key":"3933_CR19","unstructured":"Monaco A, Aurino A, Grimaldi MC, Ferrandino I (2015) Neurotoxicity induced by AlCl\u2083 in zebrafish brain. pp 176\u2013176"},{"key":"3933_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.614643","volume":"14","author":"A Munaf\u00f2","year":"2020","unstructured":"Munaf\u00f2 A, Burgaletto C, Di Benedetto G, Di Mauro M, Di Mauro R, Bernardini R, Cantarella G (2020) Repositioning of immunomodulators: a ray of hope for Alzheimer\u2019s disease? Front Neurosci 14:614643. https:\/\/doi.org\/10.3389\/fnins.2020.614643","journal-title":"Front Neurosci"},{"key":"3933_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176332","volume":"965","author":"AP Nadiga","year":"2024","unstructured":"Nadiga AP, Krishna KL (2024) A novel zebrafish model of Alzheimer\u2019s disease by aluminium chloride; involving nitro-oxidative stress, neuroinflammation, and the cholinergic pathway. Eur J Pharmacol 965:176332. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176332","journal-title":"Eur J Pharmacol"},{"key":"3933_CR22","doi-asserted-by":"publisher","unstructured":"Norton WH, Manceau L, Reichmann F (2019) The visually mediated social preference test: a novel technique to measure social behavior and behavioral disturbances in zebrafish. In Psychiatric Disorders: Methods and Protocols pp 121\u2013132. https:\/\/doi.org\/10.1007\/978-1-4939-9554-7_8","DOI":"10.1007\/978-1-4939-9554-7_8"},{"key":"3933_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.590057","volume":"7","author":"A Ogi","year":"2020","unstructured":"Ogi A, Licitra R, Naef V, Marchese M, Fronte B, Gazzano A et al (2020) Social preference tests in zebrafish: a systematic review. Frontiers in Veterinary Science 7:590057. https:\/\/doi.org\/10.3389\/fvets.2020.590057","journal-title":"Frontiers in Veterinary Science"},{"issue":"4","key":"3933_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3329\/bjp.v18i4.67354","volume":"18","author":"S Pal","year":"2023","unstructured":"Pal S, Mandal S, Firdous SM (2023) Neurobehavioral assessment of seed extract of Swietenia mahagoni on zebrafish model. Bangladesh J Pharmacol 18(4):130\u2013137. https:\/\/doi.org\/10.3329\/bjp.v18i4.67354","journal-title":"Bangladesh J Pharmacol"},{"key":"3933_CR25","first-page":"231","volume-title":"Neuromethods","author":"M Pham","year":"2012","unstructured":"Pham M, Raymond J, Hester J, Kyzar E, Gaikwad S, Bruce I et al (2012) Assessing social behaviour phenotypes in adult zebrafish: shoaling, social preference, and mirror biting tests. Neuromethods. Humana Press, Totowa, pp 231\u2013246"},{"key":"3933_CR26","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902024000223618","volume":"60","author":"K Rathi","year":"2024","unstructured":"Rathi K, Wavhale R, Bhole R, Undale V, Chaudhari S (2024) Rational drug repurposing for Alzheimer\u2019s treatment using in-silico ligand and structure-based approaches. Braz J Pharm Sci 60:e23618. https:\/\/doi.org\/10.1590\/s2175-97902024000223618","journal-title":"Braz J Pharm Sci"},{"key":"3933_CR27","doi-asserted-by":"publisher","unstructured":"Shoaib M, Amjad Kamal M, Mohd Danish Rizvi S (2017) Repurposed drugs as potential therapeutic candidates for the management of Alzheimer\u2019s disease. Curr Drug Metab 18(9):842-852. https:\/\/doi.org\/10.2174\/1389200218666170607101622","DOI":"10.2174\/1389200218666170607101622"},{"key":"3933_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2012.02.064","volume":"1451","author":"AM Stewart","year":"2012","unstructured":"Stewart AM, Gaikwad S, Kyzar E, Kalueff AV (2012) Understanding spatio-temporal strategies of adult zebrafish exploration in the open field test. Brain Res 1451:44\u201352. https:\/\/doi.org\/10.1016\/j.brainres.2012.02.064","journal-title":"Brain Res"},{"key":"3933_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.653377","volume":"15","author":"SR Stott","year":"2021","unstructured":"Stott SR, Wyse RK, Brundin P (2021) Drug repurposing for Parkinson\u2019s disease: the international linked clinical trials experience. Front Neurosci 15:653377. https:\/\/doi.org\/10.3389\/fnins.2021.653377","journal-title":"Front Neurosci"},{"issue":"21","key":"3933_CR30","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.3390\/molecules27217374","volume":"27","author":"JK Tan","year":"2022","unstructured":"Tan JK, Nazar FH, Makpol S, Teoh SL (2022) Zebrafish: a pharmacological model for learning and memory research. Molecules 27(21):7374. https:\/\/doi.org\/10.3390\/molecules27217374","journal-title":"Molecules"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03933-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-03933-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03933-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:36:45Z","timestamp":1757140605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-03933-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3933"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-03933-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments have been completed with the CPCSEA, and experimental ethics (198\/PO\/Re\/S\/2000\/CPCSEA). Every attempt has been made to decrease animal struggle and to lessen the range of animals utilized in all experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}